Pharmaceutical Containers Produced by Injection Blow Moulding Without Barrier Overmoulding

A reciprocating-screw injection blow moulding cell configured for monolayer pharmaceutical containers typically couples a 40 mm diameter plasticating screw with a three-station rotary indexing table operating at 120° increments; the first station injects a preform around a hollow core rod, the second station transfers the preform at a surface temperature above the resin's heat deflection temperature into a blow cavity, and the third station ejects the finished container. The platform for 100 mL to 500 mL high-density polyethylene or polypropylene bottles uses shot capacities between 180 g and 450 g, plasticating screw length-to-diameter ratio of 20:1 to 25:1, and hydraulic injection pressure capability of 120 MPa to 160 MPa. Barrel temperature profiles for blow moulding grades of high-density polyethylene typically run 150 °C at the feed throat, 180 °C in the compression zone, 200 °C in the metering zone, and 205 °C at the nozzle; polypropylene profiles are set 20 °C to 30 °C higher. Melt pressures during injection range from 80 MPa to 140 MPa, with packing pressures of 40 MPa to 70 MPa applied for 1.5 s to 3.5 s to reduce sink marks at the neck-shoulder junction. The preform mould cavities are maintained at 10 °C to 30 °C using turbulent water flow, while core rod temperature is controlled between 80 °C and 110 °C by circulating oil through internal channels. This differential solidifies the inner wall rapidly enough to preserve a smooth core-rod surface while leaving the outer preform skin sufficiently hot for re-expansion. The absence of an overmoulded barrier layer means that sidewall thickness, polymer crystallinity, and orientation must supply all resistance to moisture and oxygen ingress; therefore every millimetre of wall thickness and every degree of preform surface temperature becomes part of the permeation control strategy. Cycle times for six-cavity production of a 250 mL HDPE bottle with 1.2 mm average sidewall thickness generally fall between 9 s and 14 s, and the machine footprint may be 30% to 40% smaller than a comparable co-injection barrier system because the second injection unit, secondary melt channels, and parison conditioning station are absent.

Production-scale failure patterns associated with this simplified architecture include gate vestige stress cracking at the base, non-uniform sidewall haze caused by insufficient blow pressure, and neck finish ovality from premature ejection. Because there is no barrier overmoulding to mask localized thinning, sidewall thickness distribution must be verified by sectioning along the preform gate, sidewall centre, and shoulder tangent. In multi-cavity tools, the maximum acceptable cavity-to-cavity wall thickness variation is often held below 0.1 mm for a 1.2 mm nominal wall to prevent preferential ingress zones in the finished pack. The injection station must also maintain a stable cushion of 3 mm to 8 mm during every shot to avoid decompression at the gate and to ensure consistent packing pressure transmission across all cavities.

What Limits Monolayer Moisture Vapour Transmission in HDPE and PP Containers?

The container moisture vapour transmission rate is governed by the ratio of water vapour permeability coefficient to sidewall thickness and by the internal-to-external partial-pressure differential, as measured according to ASTM F1249. For a monolayer container without barrier overmoulding, the steady-state transmission rate is directly proportional to exposed surface area and the water vapour pressure gradient, and inversely proportional to wall thickness. The relationship applies most reliably to hydrophobic semicrystalline olefins when the polymer is above its glass transition temperature during testing, which is the case for high-density polyethylene and polypropylene at the standardised condition of 38 °C and 90% RH. In contrast, cyclic olefin copolymer and polyethylene terephthalate lie at different points in the permeability spectrum because chain rigidity and polarity alter both diffusion and solubility coefficients. The table below compiles typical resin-supplier values normalised to 1 mm plaque thickness; finished container transmission is obtained by dividing the normalised value by the actual minimum sidewall thickness.

Polymer typeDensity ISO 1183-1Melt flow rate ISO 1133-1WVTR ASTM F1249 (38 °C, 90% RH)OTR ASTM D3985 (23 °C, 0% RH)HDT ISO 75-2/B
High-density polyethylene0.950–0.965 g/cm³0.3–1.2 g/10 min at 190 °C/2.16 kg0.3–0.5 g·mm/m²·day800–1,600 cm³·mm/m²·day·atm45–60 °C
Polypropylene impact copolymer0.900–0.910 g/cm³1.0–2.5 g/10 min at 230 °C/2.16 kg0.3–0.7 g·mm/m²·day1,200–2,500 cm³·mm/m²·day·atm65–85 °C
Cyclic olefin copolymer0.98–1.02 g/cm³6–60 g/10 min at 260 °C/2.16 kg0.02–0.05 g·mm/m²·day200–600 cm³·mm/m²·day·atm130–170 °C
Polyethylene terephthalate1.30–1.34 g/cm³intrinsic viscosity 0.74–0.84 dL/g1.5–4.0 g·mm/m²·day40–90 cm³·mm/m²·day·atm60–70 °C

For a 1.2 mm sidewall high-density polyethylene container, the normalised water vapour transmission range of 0.3–0.5 g·mm/m²·day corresponds to a container-sidewall transmission rate of approximately 0.25–0.42 g/m²·day at 38 °C and 90% RH. This means that a 250 mL bottle with an exposed surface area of 0.018 m² may transmit between 4.5 mg/day and 7.6 mg/day under accelerated conditions. Such values are acceptable for desiccated solid oral dose packaging only when the desiccant mass and the closure seal contribute sufficient additional moisture capacity. For liquid formulations requiring a tight container classification under USP <671>, the same wall thickness may be adequate in polyethylene but inadequate in polypropylene if the drug product hydrolysis threshold is below 2% total water uptake over shelf life.

Across the major olefin families used for monolayer pharmaceutical containers, the molecular architecture determines not only permeation resistance but also injection moulding flow length, core rod release force, and drop impact performance at sub-ambient distribution temperatures. High-density polyethylene grades with density below 0.950 g/cm³ generally improve environmental stress crack resistance, as measured by ASTM D1693 under 10% Igepal CO-630 at 50 °C, but reduce the heat deflection temperature and may increase creep at elevated warehouse temperatures. Grades above 0.960 g/cm³ increase sidewall stiffness and allow marginal down-gauging, but they reduce low-temperature impact resistance and can exhibit greater gate vestige notch sensitivity. Polypropylene impact copolymers used in pharmaceutical IBM containers typically contain 8% to 15% ethylene-propylene rubber phase, which improves drop impact at -20 °C but raises haze and may increase extractable hydrocarbon oligomers if the rubber phase is not adequately stabilised. For monolayer containers without barrier overmoulding, the additive package is restricted to food-contact or pharmaceutical-grade stabilisers, usually hindered phenolics, phosphites, and acid scavengers at total loadings below 0.2 wt%. Metal deactivators, amine-based processing aids, and migratory antistatic agents are generally avoided because they can increase extractables or impart colour under sterilising irradiation.

Blow Station Conditioning Defines Sidewall Thickness Distribution Without Overmoulding

The preform surface temperature, measured by infrared pyrometer at ejection from the injection station, should be maintained within a ±5 °C window; for high-density polyethylene this window often lies between 115 °C and 125 °C, while for polypropylene impact copolymer it lies between 125 °C and 135 °C. Above the upper limit, the outer preform skin can adhere to the blow cavity or exhibit excessive chill marks at the contact points; below the lower limit, the material cannot stretch uniformly and produces thin spots at the base corners and shoulder transition. The blow station cavity temperature is held between 10 °C and 30 °C for high-density polyethylene and between 15 °C and 40 °C for polypropylene to provide rapid surface solidification without causing warpage. Blow pressure is applied in a ramped profile rather than as a single step: an initial 0.3 MPa pre-blow expands the preform slowly and centres it in the cavity, a second 0.8 MPa phase completes the sidewall replication, and a final 1.0 MPa hold phase maintains contact during cooling. Pressure transducers at the blow pin monitor actual cavity pressure; a decay of more than 0.05 MPa before 2 s indicates leakage at the neck or an undersized preform. The blow ratio for pharmaceutical bottles typically ranges from 2.5:1 to 4:1, with axial draw ratios of 2:1 to 3.5:1 and hoop draw ratios of 1.5:1 to 2.5:1. In the absence of a barrier overmoulding layer, the neck finish, shoulder, sidewall, and base must be formed from the same monolayer preform, so the preform wall thickness profile must be deliberately tapered. Preforms for 250 mL containers may have a neck wall of 2.0 mm to 2.5 mm, a sidewall of 3.0 mm to 4.0 mm, and a base pad of 4.0 mm to 5.0 mm before blowing. Failure to maintain this profile results in either underblown bases with excessive thickness and cooling time, or sidewall thinning below 0.8 mm in the lower panel zone.

Core rod temperature control is a further determinant of monolayer container quality. The core rod surface must remain above the preform inner-wall solidification threshold long enough to allow repeated use without the preform sticking, but low enough to chill the inner surface and reduce cycle time. Internal circulating oil is maintained at 80 °C to 110 °C for high-density polyethylene and 90 °C to 120 °C for polypropylene. If core rod surface finish exceeds 0.8 µm Ra, ejection force increases and the preform may distort or develop stress whitening at the neck. Production-scale observation in multi-cavity lines shows that a core rod temperature difference of 5 °C across the tool can produce measurable neck finish ovality above 0.15 mm, which becomes critical when the container must retain a child-resistant closure under ISO 8317. The blow station must also maintain alignment between the core rod and the cavity within 0.03 mm total indicated runout to prevent non-uniform wall thickness at the parting line. Parting line defects in monolayer containers are not hidden by an overmoulded layer and are inspected under polarised light for stress concentration.

When Oxygen-Sensitive Liquid Formulations Force Monolayer Limits

Monolayer high-density polyethylene and polypropylene containers without barrier overmoulding present a high oxygen transmission rate relative to polyethylene terephthalate or multilayer structures. Using the normalised oxygen transmission range of 800–1,600 cm³·mm/m²·day·atm for high-density polyethylene and dividing by a 1.2 mm sidewall, the container-sidewall transmission rate is approximately 670–1,330 cm³/m²·day·atm at 23 °C and 0% RH. Under atmospheric oxygen partial pressure of 0.21 atm, a 250 mL bottle with 0.018 m² exposed area may admit between 2.5 cm³ and 5.0 cm³ of oxygen per day. This calculated ingress rate exceeds the oxidative capacity considered tolerable for many oxygen-sensitive liquid formulations unless the formulation contains an oxygen scavenger, the primary packaging is overwrapped in a low-permeability foil laminate, or the headspace is inerted with nitrogen to residual oxygen below 0.5%. The limitation becomes more severe when the container is stored at elevated temperatures or when the closure liner contributes additional oxygen permeation. A closure with a polyethylene foam liner can increase the total package oxygen ingress by 15% to 30% relative to the container body alone, particularly if the liner is not coated with a barrier film.

For parenteral or ophthalmic liquid formulations requiring oxygen control, the absence of a barrier overmoulding layer usually excludes monolayer polyolefin containers unless the drug product is inherently oxygen-stable or packaged under nitrogen with an oxygen-absorber sachet. Polyethylene terephthalate provides lower oxygen transmission but is more difficult to injection blow mould on standard olefin tooling because it requires 4 h to 6 h desiccant drying to below 50 ppm moisture and a barrel profile from 260 °C to 280 °C. Cyclic olefin copolymer offers reduced moisture transmission but only moderate oxygen barrier, and its high melt viscosity at low shear rates can create gate blush at the preform injection gate. The operational boundary is therefore set by the drug product’s oxygen sensitivity, the ICH long-term storage condition of 25 °C/60% RH, and the labelled shelf life. Published data for specific monolayer configurations under tropical-zone storage conditions is limited, so accelerated oxygen-ingress modelling should be supported by package-level oxygen content testing at multiple time points rather than reliance on resin permeation coefficients alone.

During stability protocols for moisture-sensitive oral solid products, containers without barrier overmoulding are qualified by measuring not only the container transmission rate but also the effective headspace moisture accumulation in a packed configuration with desiccant sachets. The package-level test is necessary because the closure seal, the tablet or capsule fill, and the desiccant capacity interact with the container wall in a manner that cannot be predicted from the container water vapour transmission rate alone. A filled 250 mL high-density polyethylene bottle sealed with an induction liner may behave differently from the empty container because the product and desiccant create an internal humidity sink that initially suppresses the partial-pressure differential across the wall. Over time, as the desiccant approaches equilibrium, the container approaches the steady-state transmission rate given by ASTM F1249. The compliance checklist below summarises the principal standards applied to monolayer pharmaceutical containers produced by injection blow moulding without barrier overmoulding.

RequirementStandard or methodConditionTypical acceptance criterion
Material identityUSP <661.1>, Ph. Eur. 3.1.3, 3.1.6FTIR or DSCMatches reference spectrum or thermogram
Extractable heavy metalsUSP <661.1>, Ph. Eur. 3.1.3Acid digestion of extraction residueAs specified in current monograph
Non-volatile residueUSP <661.1>Water and ethanol extractionAs specified in current monograph
Biological reactivityUSP <88>Sodium chloride injection, vegetable oil extractMeets Class VI for parenteral or systemic packaging
Light transmissionUSP <661.1>Spectrophotometric scan 290–450 nmLight-resistant containers meet monograph limits
Moisture permeationUSP <671>Controlled humidity chamber, weight gainTight or well-closed classification as specified
Gross leak integrityASTM F2096Internal pressurisation under waterNo continuous bubble stream at specified pressure
Child-resistant closure functionISO 831723 °C/50% RH conditioningMeets child-resistant panel test criteria

Dimensional qualification of injection blow moulded monolayer containers uses sectioned-weight analysis, wall-thickness mapping at defined points, and volumetric gravimetric verification. The neck finish dimensions are checked against the closure manufacturer’s gauge limits, typically with a go/no-go gauge and an optical profile projector reading to 0.01 mm. The finish inner diameter and thread depth are controlled more tightly than the body dimensions because closure torque retention and seal compression govern package integrity. For a 250 mL bottle with a 28 mm neck finish, the finish inner diameter tolerance may be held within ±0.10 mm, while the body panel width may tolerate ±0.50 mm. Container volume is checked gravimetrically at 23 °C using distilled water; the overflow capacity must exceed the labelled fill volume by sufficient headspace to allow product reconstitution if required. In multi-cavity production, the statistical process control plan tracks fill weight, preform weight, ejection force, and blow pressure trace; a process deviation in any of these variables triggers sectioning and barrier-property re-testing because the absence of a barrier overmoulding layer leaves no secondary topology to compensate for local wall thinning.

Extractable Profiles for Olefin and Cyclic Olefin Containers

Extractable testing of monolayer containers produced by injection blow moulding without barrier overmoulding is conducted according to USP <1663> and is designed to identify low-molecular-weight organic and inorganic species that could migrate from the container into the drug product. The extraction solvents are selected to bracket the polarity and pH range of the intended formulation: purified water, 0.1 N hydrochloric acid, 0.1 N sodium hydroxide, 50% ethanol, and isopropyl alcohol are common. Intact containers are filled with the extraction solvent and stored at 40 °C for 30 days or 60 °C for 10 days, depending on the regulatory filing strategy. For high-density polyethylene and polypropylene, the main extractables are low-molecular-weight saturated hydrocarbons, chain fragments, and residual antioxidants. Total organic carbon in aqueous extracts from well-stabilised pharmaceutical grades may be below 5 mg/L after accelerated extraction, but batch-to-batch variation is observed when regrind content or processing temperature increases. Cyclic olefin copolymer containers generally produce lower hydrocarbon extractables but may require monitoring for residual catalyst metals and aromatic solvent residues from the polymerisation process. The absence of a barrier overmoulding layer simplifies the extractable profile because there is no tie-layer, adhesive, or secondary melt stream to contribute species from a multilayer interface.

Leachable assessment for a specific drug product follows USP <1664> and is performed on the unaged and aged container under stressed conditions relevant to the intended storage temperature and fill configuration. The leachable profile of a monolayer polyolefin container is influenced by the processing stabiliser package, the inclusion of regrind, and the thermal history during injection blow moulding. Regrind proportions above 20% in polypropylene can raise the concentration of low-molecular-weight oligomers in the container wall and increase extractable levels in 50% ethanol extraction. For high-density polyethylene, the use of regrind above 30% may reduce environmental stress crack resistance and increase variability in wall thickness. Without an overmoulded barrier layer, any process-induced surface oxidation becomes part of the drug-contact surface; therefore the extrusion and injection temperatures must be controlled to prevent carbonyl formation on the preform surface. Packaging engineers must also recognise that monolayer polyolefin containers have defined operational boundaries: they are not suitable for extended storage of volatile formulations because of high organic vapour transmission, and they are not appropriate for drugs requiring visible inspection through a glass-clear wall unless a clarified random copolymer or cyclic olefin copolymer is selected.

Related Articles